Search

You searched for "TURP"

125 results found

All you need to know about percutaneous nephrolithotomy: supine versus prone and mini versus traditional

1 September 2014 | | URO - Endourology & Stones
Introduction Since the first percutaneous nephrolithotomy (PCNL), the technique has undergone many innovations, including modifications in positioning, miniaturisation of instruments and combination with retrograde intra-renal surgery (see Table 1 for an outline of the history of the technique). Controversy has...

Innovative catheter receives “bacteria-phobic™” claim approval from notified body: positive evaluation affirms device resistance to bacterial colonisation

4 September 2019 | Research & Development
Camstent Ltd’s coated catheter, which has been developed to limit attachment of bacteria to its surfaces, a known source of Catheter Acquired Urinary Tract Infection (CAUTI), has been awarded approval...

University of Birmingham and Nonacus win national award for pioneering at-home bladder cancer test

3 August 2026 | Urology News
University of Birmingham researchers and Birmingham cancer testing company Nonacus have won a national Medilink award for their work on GALEAS Bladder, a non-invasive urine test now being used by NHS patients. They received the Partnership between Academia and Business...

The 10 commandments of laparoscopic urology

1 March 2015 | | URO - Core Urology
Laparoscopic urologic procedures continue to attract the interest of trainees, consultants and the public, and the demand for training is on the increase [1,2,3]. The vast majority of laparoscopic procedures are laparoscopic nephrectomies and this is certainly the most common...

Recent developments in bladder cancer – NMIBC

3 May 2022 | | URO - Urologic Oncology
Every year, roughly 10,300 individuals are diagnosed with bladder cancer in the UK, making it the 11th most common cancer in the UK, and the eighth most common cancer in men [1]. Of those diagnosed with the disease, 75-85% will...

The stonecutters of 17th Century London

1 July 2015 | | URO - Endourology & Stones, URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I told you about the prostatic punch. If you...

What the Dickens?

1 November 2018 | | URO - Andrology, URO - Endourology & Stones, URO - Functional / Reconstructive Urology, URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article we were in the modern world of films, this...

Should it be a mandatory requirement for medical students to receive the COVID-19 vaccine to attend clinical attachments?

11 August 2021 | | URO - Core Urology
The vast majority of medical students have positive attitudes towards the COVID-19 vaccine for themselves and patients, however, what about the small inevitable minority who resist it? Should they be prevented from attending clinical attachments in the NHS? It is...

Discovering urology during the foundation programme

6 November 2024 | | URO - Core Urology
My journey to finding urology as a chosen career was not linear. During medical school, I always enjoyed studying urological and renal pathologies. I was exposed to one week of urology placement during my fourth year ‘surgical block’, where I...

An amateur’s trek into the Urology Boot Camp

9 September 2025 | | URO - Core Urology
Driven by a strong desire to pursue a career in medicine, I was lucky to get an opportunity to attend the Urology Boot Camp at Leeds while still in sixth form. Although urology is a postgraduate specialty, I wanted to...

New £1.9M drug trial could delay relapse for prostate cancer patients

5 November 2025
A new drug could keep cancer under control for longer for men with advanced prostate cancer and will be tested in a new trial funded with £1.9 million from Prostate Cancer UK. Current treatments, like chemotherapy or hormone-targeting therapies, can...

IBSA UK&I launches Perovial®: the first licensed injectable option for men with acute Peyronie’s disease

2 February 2026 | Company Profiles, Recruitment & Personnel
A clinically supported option for early intervention in a historically underdiagnosed and undertreated condition. IBSA UK&I today (Monday 2 February 2026) announces the launch of Perovial®, the first licensed hyaluronic acid injectable indicated for the management of Peyronie’s disease (PD)...